Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Joulie solution (also known as Joulie's Solution or Potion Joulié) is a compounded oral phosphate supplement primarily used for the treatment of hypophosphatemia, particularly in pediatric populations. It was developed by hospital pharmacists, notably within the Assistance Publique – Hôpitaux de Paris (AP-HP) network, as a stable alternative to commercial phosphate products like Phosphoneuros during supply shortages. The formulation typically contains sodium phosphate (often a mixture of dibasic and monobasic sodium phosphate to achieve a specific pH and phosphorus concentration) and provides approximately 67.4 mg/mL of elemental phosphorus. As a small molecule oral solution, it is valued for its physicochemical stability and compliance with microbiological standards, allowing for flexible dosing in clinical settings where standardized commercial products are unavailable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Joulie solution.